A new COVID-19 vaccine considered effective against the Omicron variant will be available in Japan to all people who have completed at least two coronavirus inoculations from as early as mid-October, the government said Monday.The bivalent vaccine, so named for its combination of ingredients deriving from existing COVID-19 shots and from the Omicron variant's BA.1 subtype, has been reported to provide some increase in neutralizing antibodies against the BA.5 subtype currently prevalent across the country.The plan was approved by a health ministry panel at a time when Japan is experiencing a…READ FULL ARTICLE